“Adalimumab and Etanercept in the Treatment of Rheumatoid Arthritis and Spondyloarthropathies: Budget Impact Model of Dose Reduction ”. Journal of Pharmacy and Nutrition Sciences , vol. 4, no. 3, June 2014, pp. 170-6, https://doi.org/10.6000/1927-5951.2014.04.03.1.